The FDA is undergoing significant changes, including major job reductions and administrative restructuring, which may impact its effectiveness. Peter Marks, a key figure in advancing gene and cell therapies, has…
A significant restructuring is occurring within the U.S. FDA and HHS, affecting thousands of positions and raising concerns about the future of innovative medicine in America. Peter Marks, former director…
The FDA undergoes significant restructuring, impacting thousands of jobs, including the pivotal exit of Peter Marks. Peter Marks, former head of the CBER, was instrumental in advancing cell and gene…